Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 10.25
-0.13 (-1.25%)
Oct 16, 2026, 3:37 PM GMT
Creo Medical Group Revenue
Creo Medical Group had revenue of 2.20M GBP in the half year ending June 30, 2025, a decrease of -85.99%. This brings the company's revenue in the last twelve months to 4.60M, down -72.46% year-over-year. In the year 2024, Creo Medical Group had annual revenue of 4.00M. That makes Creo Medical Group the 37,670th largest company in the world by revenue and 734th in the United Kingdom.
Revenue (ttm)
4.60M
Revenue Growth
-72.46%
P/S Ratio
6.80
Revenue / Employee
67.31K
Employees
104
Market Cap
47.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.00M | - | - |
| Dec 31, 2023 | 4.00M | -23.20M | -85.29% |
| Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
| Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
| Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
| Dec 31, 2019 | 13.47K | - | - |
| Jun 30, 2018 | - | - | - |
| Jun 30, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Smith & Nephew | 4.77B |
| AOTI, Inc. | 52.74M |
| EKF Diagnostics Holdings | 51.35M |
| Inspiration Healthcare Group | 47.55M |
| NIOX Group | 47.50M |
| Surgical Innovations Group | 11.48M |
| RUA Life Sciences | 4.62M |
| Proteome Sciences | 3.77M |
Creo Medical Group News
- 15 days ago - Creo Records Lower H1 Loss Of £6 Mln; Full Year Revenue Growth Estimated At 50%-60% - Nasdaq